Viatris’ Dividend Reinvestment and Share Purchase Plan

May 9, 2022 at 7:30 AM EDT

On May 9, 2022, Viatris announced that its Board of Directors has authorized a Dividend Reinvestment and Share Purchase Plan (“DRIP”). The DRIP will allow shareholders to automatically reinvest all or a portion of the cash dividends paid on their shares of Viatris common stock and to make certain additional optional cash investments in Viatris common stock.

The DRIP will be administered by American Stock Transfer & Trust Company, LLC (“AST”), Viatris’ transfer agent. Reinvested cash dividends on Viatris common stock and cash investments under the DRIP will be used to purchase shares of Viatris common stock, which, at Viatris’ option, either will be (1) newly issued or treasury shares purchased by AST from Viatris or (2) purchased on behalf of DRIP participants in the open market or in privately negotiated transactions by an independent agent appointed by AST. Initially, Viatris will issue the shares under the DRIP directly at no discount to the average of the high and low prices of Viatris common stock as reported on the NASDAQ Stock Market for the investment date.

DRIP enrollment materials and information will be distributed to Viatris shareholders of record. Registered shareholders of Viatris who wish to participate in the DRIP should complete and sign the distributed enrollment form and return it to AST by mail as indicated on the form. Beneficial shareholders who wish to enroll in the DRIP should coordinate with the applicable broker, bank or other nominee who is the record owner of their shares to discuss logistics for participation in the DRIP. For more information on how to enroll or any other inquiries, please contact AST by phone at (877) 536-1556 (toll-free) or (212) 434-0036 (toll) or via the Internet at

Participation in the DRIP is voluntary and may be terminated at any time. Shareholders who elect not to participate in the DRIP, or who elect to participate in the DRIP with respect to optional cash investments only and not with respect to cash dividend reinvestments, will continue to receive cash dividends paid on their shares of Viatris common stock, if and when declared by Viatris’ Board of Directors, solely in cash. Nothing contained in the DRIP obligates Viatris’ Board of Directors to declare or pay a dividend in the future, and the DRIP does not represent a guarantee of future dividends.

Dividend reinvestments under the DRIP are expected to begin with the dividend declared by Viatris’ Board of Directors in respect of the quarter ended March 31, 2022. Shareholders must enroll in the DRIP by 5:00 p.m. (ET) on the record date of May 24, 2022 for these dividends to qualify for participation in the DRIP.

The foregoing description of the DRIP is only a summary; the full terms and conditions of the DRIP are set forth under the heading “Description of the Plan” in the prospectus available as part of the registration statement filed by Viatris with the Securities and Exchange Commission (the “SEC”) on the SEC’s website ( Shareholders should read the DRIP prospectus carefully before deciding to participate in the DRIP or make an investment decision under the DRIP.

This communication does not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The offering is being made only by means of a prospectus. Viatris has filed a registration statement (including a prospectus) relating to the DRIP with the SEC. A copy of the registration statement (including the prospectus) is available electronically from the SEC’s website ( and may also be obtained from AST by phone at (877) 536-1556 (toll-free) or (212) 434-0036 (toll) or via the Internet at

This communication contains “forward-looking statements”. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may often be identified by the use of words such as “will”, “may”, “could”, “should”, “would”, “project”, “believe”, “anticipate”, “expect”, “plan”, “estimate”, “forecast”, “potential”, “pipeline”, “intend”, “continue”, “target”, “seek” and variations of these words or comparable words. Because forward-looking statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. For more detailed information on the risks and uncertainties associated with Viatris, see the risks described in Viatris’ Annual Report on Form 10-K for the year ended December 31, 2021 and our other filings with the SEC. You can access Viatris’ filings with the SEC through the SEC website at or through our website, and Viatris strongly encourages you to do so. Viatris routinely posts information that may be important to investors on our website at, and we use this website address as a means of disclosing material information to the public in a broad, non-exclusionary manner for purposes of the SEC’s Regulation Fair Disclosure (Reg FD). Viatris undertakes no obligation to update any statements herein for revisions or changes after the date of this communication other than as required by law.